Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 47  Show
  1. 1
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H., Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.
    Malek J.
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Blood.
    Source: UniProtKB/TrEMBL (unreviewed).

    This publication is cited by 50448 other entries.

  2. 2
    "The DNA sequence and biological annotation of human chromosome 1."
    Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.
    Prigmore E.
    Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/TrEMBL (unreviewed).

    This publication is cited by 5922 other entries.

  3. 3
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/TrEMBL (unreviewed).

    This publication is cited by 8769 other entries.

  4. 4
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/TrEMBL (unreviewed).

    This publication is cited by 18117 other entries.

  5. 5
    "Toward a comprehensive characterization of a human cancer cell phosphoproteome."
    Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., Mohammed S.
    J. Proteome Res. 12:260-271(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: Sequences.
    Source: UniProtKB/TrEMBL (unreviewed).

    This publication is cited by 13410 other entries.

  6. 6
    Ensembl
    Submitted (DEC-2013) to UniProtKB
    Cited for: IDENTIFICATION.
    Source: UniProtKB/TrEMBL (unreviewed).
  7. 7
    "Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia."
    Prima V., Gore L., Caires A., Boomer T., Yoshinari M., Imaizumi M., Varella-Garcia M., Hunger S.P.
    Leukemia 19:806-813(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Annotation: data implicate MEF2D in human cancer and suggest that MEF2D/DAZAP1 and/or DAZAP1/MEF2D contribute to leukemogenesis by altering signaling pathways normally regulated by wild-type MEF2D and DAZAP1.
    Source: GeneRIF:4209.

    This publication is cited by 2 and mapped to 6 other entries.

  8. 8
    "Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain."
    Zhu B., Ramachandran B., Gulick T.
    J. Biol. Chem. 280:28749-28760(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Annotation: A conserved pattern of alternative splicing in vertebrate MEF2 (myocyte enhancer factor 2) genes generates an acidic activation domain in MEF2 proteins selectively in tissues where MEF2 target genes are highly expressed. (MEF2).
    Source: GeneRIF:4209.

    This publication is cited by 5 and mapped to 22 other entries.

  9. 9
    "Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications."
    Zhao X., Sternsdorf T., Bolger T.A., Evans R.M., Yao T.-P.
    Mol. Cell. Biol. 25:8456-8464(2005) [PubMed] [Europe PMC] [Abstract]
    Category: PTM / Processing.
    Annotation: histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications regulate MEF2.
    Source: GeneRIF:4209.

    This publication is cited by 2 and mapped to 21 other entries.

  10. 10
    "Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2."
    Gregoire S., Xiao L., Nie J., Zhang X., Xu M., Li J., Wong J., Seto E., Yang X.J.
    Mol. Cell. Biol. 27:1280-1295(2007) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Annotation: These results reveal an unexpected role for HDAC3 and suggest a novel pathway through which MEF2 activity is controlled in vivo.
    Source: GeneRIF:4209.

    This publication is mapped to 34 other entries.

  11. 11
    "Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations."
    Lu Y., Dolle M.E., Imholz S., van 't Slot R., Verschuren W.M., Wijmenga C., Feskens E.J., Boer J.M.
    J. Lipid Res. 49:2582-2589(2008) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech.
    Annotation: Not Associated with METABOLIC: plasma HDL cholesterol (HDL-C) levels. [GAD:590355]. Observational study of gene-disease association. (HuGE Navigator). [GeneRIF:4209].
    Source: GAD:590355, GeneRIF:4209.

    This publication is mapped to 1555 other entries.

  12. 12
    "Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis."
    Liu G., Han J., Profirovic J., Strekalova E., Voyno-Yasenetskaya T.A.
    Angiogenesis 12:1-15(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Interaction.
    Annotation: MEF2 proteins are an important component in Galpha13-mediated angiogenesis.
    Source: GeneRIF:4209.

    This publication is mapped to 21 other entries.

  13. 13
    "Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy."
    Yang Q., She H., Gearing M., Colla E., Lee M., Shacka J.J., Mao Z.
    Science 323:124-127(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: MEF2D levels were increased in the brains patients with Parkinson's disease.
    Source: GeneRIF:4209.

    This publication is mapped to 26 other entries.

  14. 14
    "High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men."
    Yerges L.M., Klei L., Cauley J.A., Roeder K., Kammerer C.M., Moffett S.P., Ensrud K.E., Nestlerode C.S., Marshall L.M., Hoffman A.R., Lewis C., Lang T.F., Barrett-Connor E., Ferrell R.E., Orwoll E.S., Zmuda J.M.
    J. Bone Miner. Res. 24:2039-2049(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: Observational study of gene-disease association. (HuGE Navigator).
    Source: GeneRIF:4209.

    This publication is mapped to 1916 other entries.

  15. 15
    "Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals."
    Oguri M., Kato K., Yokoi K., Yoshida T., Watanabe S., Metoki N., Yoshida H., Satoh K., Aoyagi Y., Nozawa Y., Yamada Y.
    Am. J. Hypertens. 23:70-77(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech, Sequences.
    Annotation: Observational study of gene-disease association. (HuGE Navigator). [GeneRIF:4209]. Not Associated with CARDIOVASCULAR: hypertension. [GAD:590353].
    Source: GAD:590353, GeneRIF:4209.

    This publication is mapped to 596 other entries.

  16. 16
    Category: Function, Pathology & Biotech.
    Annotation: Observational study of gene-disease association. (HuGE Navigator).
    Source: GeneRIF:4209.

    This publication is mapped to 18812 other entries.

  17. 17
    "Association of genetic variants with hemorrhagic stroke in Japanese individuals."
    Yoshida T., Kato K., Yokoi K., Oguri M., Watanabe S., Metoki N., Yoshida H., Satoh K., Aoyagi Y., Nozawa Y., Yamada Y.
    Int. J. Mol. Med. 25:649-656(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: Observational study of gene-disease association. (HuGE Navigator).
    Source: GeneRIF:4209.

    This publication is mapped to 507 other entries.

  18. 18
    Category: Function.
    Annotation: ZAC1 is a novel and previously unknown regulator of cardiomyocyte Glut4 expression and glucose uptake; MEF2 is a regulator of ZAC1 expression in response to induction of hypertrophy.
    Source: GeneRIF:4209.

    This publication is mapped to 27 other entries.

  19. 19
    "Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression."
    Aude-Garcia C., Collin-Faure V., Bausinger H., Hanau D., Rabilloud T., Lemercier C.
    Biochem. J. 430:237-244(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Annotation: MEF2A and MEF2D play dual roles in human macrophages differentiation as activators and as repressors of c-jun transcription.
    Source: GeneRIF:4209.

    This publication is mapped to 12 other entries.

  20. 20
    "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study."
    Bailey S.D., Xie C., Do R., Montpetit A., Diaz R., Mohan V., Keavney B., Yusuf S., Gerstein H.C., Engert J.C., Anand S.
    Diabetes Care 33:2250-2253(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: Observational study of gene-disease association gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator).
    Source: GeneRIF:4209.

    This publication is mapped to 18693 other entries.

  21. 21
    "Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program."
    Jablonski K.A., McAteer J.B., de Bakker P.I., Franks P.W., Pollin T.I., Hanson R.L., Saxena R., Fowler S., Shuldiner A.R., Knowler W.C., Altshuler D., Florez J.C.
    Diabetes 59:2672-2681(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Annotation: Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator).
    Source: GeneRIF:4209.

    This publication is mapped to 234 other entries.

  22. 22
    "Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients."
    She H., Yang Q., Shepherd K., Smith Y., Miller G., Testa C., Mao Z.
    J. Clin. Invest. 121:930-940(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: direct regulation of complex I by mitochondrial MEF2D underlies its neuroprotective effects and dysregulation of this pathway may contribute to Parkinson disease.
    Source: GeneRIF:4209.

    This publication is mapped to 7 other entries.

  23. 23
    "[Expression of MEF2D on nasopharyngeal carcinoma tissues and its influence of prognostic]."
    Li Y., Zhang L., Nong J., Bian S., Zhao Z., Ren Y., Lin X., Bian X.
    Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 25:840-842(2011) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech.
    Annotation: The expression of MEF2D was higher in the higher clinical stage of nasopharyngeal carcinoma but there was no correlation with survival rate.
    Source: GeneRIF:4209.

    This publication is mapped to 2 other entries.

  24. 24
    "Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease."
    Gao L., She H., Li W., Zeng J., Zhu J., Jones D.P., Mao Z., Gao G., Yang Q.
    Antioxid. Redox Signal. 20:2936-2948(2014) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech.
    Annotation: Oxidation of survival factor MEF2D inhibits its function underlies oxidative stress-induced neurotoxicity and may be a part of the Parkinson disease pathogenic process.
    Source: GeneRIF:4209.

    This publication is mapped to 6 other entries.

  25. 25
    "Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells."
    Zhang M., Truscott J., Davie J.
    Mol. Cancer 12:150-150(2013) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: The oncogenic properties of rhabdomyosarcoma cells can be partially attributed to the loss of MEF2D expression.
    Source: GeneRIF:4209.

    This publication is mapped to 2 other entries.

1 to 25 of 47  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again